Brainalyze

Reading disease out of a drop of blood

San FranciscoHealthScaling

PITCHED AT THE SAN FRANCISCO NIGHT ON 5 AUGUST 2026

Neurodegenerative disease is usually caught once symptoms are obvious, which is years after the biology changed. Brainalyze uses patented AI-enabled photonics to take a biochemical fingerprint from blood, aiming at detection early enough to act on.

The hard part of early detection is not the algorithm, it is having a signal worth running an algorithm on. Brainalyze's approach is photonic: read the biochemistry of a blood sample directly, and treat the resulting fingerprint as the data asset.

That gives the company two shots at a market. The near one is earlier detection and management of neurodegenerative disease. The longer one is the fingerprint library itself, which is the foundation companion diagnostics and precision medicine are built on.

⟶ Others in the room

If Brainalyze is your kind of company.

These founders pitched at the same startup events. The room is usually the reason people find each other.

Quail Systems

Batch release in days instead of weeks

San Francisco · Health

SOVN

An in-ear wearable that acts on your sleep, not just records it

Amsterdam · Health

MediBridge

A health record the patient owns and can carry

London · Health

⟶ Two ways in

Companies like this one are in the room every fortnight.

FOR FOUNDERSTake the stage yourself.Five minutes, real questions from the investors in the room, and a listing here afterwards if you want one. San Francisco runs on a steady rhythm.

Apply to pitch →Nights in San Francisco

FOR INVESTORSGet the next ones first.The Biweekly Drop sends the companies that stood out on stage, with what they are building and where they got to. Same format as this page.

Join the drop →Browse the directory